Enhanced endothelin(A) receptor-mediated calcium mobilization and contraction in organ cultured porcine coronary arteries.

Arterial injury models for coronary artery disease have demonstrated an enhanced expression and function of either the endothelin(A) or endothelin(B) (ET(A) or ET(B)) receptor subtype. We hypothesized that organ culture would enhance the physiological function of ET receptors in the porcine right coronary artery. Arteries were either cold stored (4 degrees C) or organ cultured (37 degrees C) for 4 days. After 4 days, the artery was either 1) sectioned into rings to measure the ET-1-induced isometric tension response (3 x 10(-10)-3 x 10(-7) M), or 2) enzymatically dispersed and the isolated smooth muscle cells imaged using fura-2 to measure the myoplasmic calcium (Ca(m)) response to 3 x 10(-8) M ET-1 ( approximately EC(50)). Isometric tension and Ca(m) to ET-1 were measured in the absence and presence of bosentan (nonselective ET(A) or ET(B) receptor antagonist), BQ788 (ET(B)-selective antagonist), and BQ123 (ET(A)-selective antagonist). Compared with cold storage, organ culture induced a 2-fold increase in tension development (3 x 10(-7) M ET-1) and Ca(m) (3 x 10(-8) M ET-1), which was inhibited with bosentan, thus confirming the enhanced responses to ET-1 were due to ET receptor activation. BQ123 also inhibited the enhanced contraction and Ca(m) responses to ET-1. In contrast, BQ788 failed to inhibit tension development and Ca(m) responses to ET-1 in organ culture and cold storage. Sarafotoxin 6C (ET(B) agonist) failed to elicit an increased Ca(m) response in organ culture compared with cold storage. Our results indicate the increased tension development and Ca(m) responses to ET-1 in organ culture are attributable to ET(A) receptors, and not ET(B) receptors.

[1]  L. Katwa,et al.  The upregulation of endothelin and its receptors in porcine coronary arteries in a double balloon injury model of restenosis , 1999, Basic Research in Cardiology.

[2]  J. Gschwend,et al.  A human arterial organ culture model of postangioplasty restenosis: results up to 56 days after ballooning. , 1999, Atherosclerosis.

[3]  M. Omata,et al.  Molecular mechanisms of endothelin-1-induced cell-cycle progression: involvement of extracellular signal-regulated kinase, protein kinase C, and phosphatidylinositol 3-kinase at distinct points. , 1999, Circulation research.

[4]  A. Newby,et al.  Fibrous cap formation or destruction--the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation. , 1999, Cardiovascular research.

[5]  Y. Urade,et al.  Selective activation of excitation‐contraction coupling pathways by ETA and ETB receptors in guinea‐pig tracheal smooth muscle , 1999, British journal of pharmacology.

[6]  D. Stewart Impact of endothelin-1 on vascular structure and function. , 1998 .

[7]  L. Edvinsson,et al.  Increased endothelin ETB contractile activity in cultured segments of human temporal artery. , 1998, Acta physiologica Scandinavica.

[8]  R. Schwartz,et al.  Selective ET(A) receptor antagonism reduces neointimal hyperplasia in a porcine coronary stent model. , 1998, Circulation.

[9]  L. Edvinsson,et al.  Appearance of contractile endothelin-B receptors in rat mesenteric arterial segments following organ culture. , 1998, Acta physiologica Scandinavica.

[10]  D. Huse,et al.  Direct medical costs of coronary artery disease in the United States. , 1998, The American journal of cardiology.

[11]  L. Edvinsson,et al.  Regional variation in appearance of vascular contractile endothelin-B receptors following organ culture. , 1998, Cardiovascular research.

[12]  E. Schiffrin,et al.  Vascular biology of endothelin. , 1998, Journal of cardiovascular pharmacology.

[13]  R. Schwartz,et al.  Enhanced endothelin-B-receptor-mediated vasoconstriction of small porcine coronary arteries in diet-induced hypercholesterolemia. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[14]  A. Grover,et al.  Endothelin contraction in pig coronary artery: receptor types and Ca(2+)-mobilization. , 1997, Molecular and cellular biochemistry.

[15]  L. Edvinsson,et al.  Plasticity of contractile endothelin‐B receptors in human arteries after organ culture , 1996, British journal of pharmacology.

[16]  A. Lerman,et al.  The role of endothelin in coronary atherosclerosis. , 1996, Mayo Clinic proceedings.

[17]  B. Fredholm,et al.  Endothelin-1 causes a prolonged protein kinase C activation and acts as a co-mitogen in vascular smooth muscle cells. , 1996, Acta physiologica Scandinavica.

[18]  A. Davenport,et al.  Endothelin receptors in human coronary artery and aorta , 1996, British journal of pharmacology.

[19]  M. Turina,et al.  Up-regulation of endothelin-B receptors in atherosclerotic human coronary arteries. , 1996, Journal of cardiovascular pharmacology.

[20]  L. Rydén,et al.  Myocardial Release of Endothelin (ET) and Enhanced ETA Receptor‐Mediated Coronary Vasoconstriction After Coronary Thrombosis and Thrombolysis in Pigs , 1995, Journal of cardiovascular pharmacology.

[21]  J Kapuscinski,et al.  DAPI: a DNA-specific fluorescent probe. , 1995, Biotechnic & histochemistry : official publication of the Biological Stain Commission.

[22]  M. Sturek,et al.  Exercise training alters the Ca2+ and contractile responses of coronary arteries to endothelin. , 1995, Journal of applied physiology.

[23]  D. Erlinge,et al.  Upregulation of a Non‐ETA Receptor in Human Arteries In Vitro , 1995, Journal of cardiovascular pharmacology.

[24]  J. D. Elliott,et al.  A role for endogenous endothelin-1 in neointimal formation after rat carotid artery balloon angioplasty. Protective effects of the novel nonpeptide endothelin receptor antagonist SB 209670. , 1994, Circulation research.

[25]  T. Godfraind Evidence for heterogeneity of endothelin receptor distribution in human coronary artery , 1993, British journal of pharmacology.

[26]  M F Rajewsky,et al.  Quantification of specific DNA O-alkylation products in individual cells by monoclonal antibodies and digital imaging of intensified nuclear fluorescence. , 1993, Carcinogenesis.

[27]  M. Sturek,et al.  Sarcoplasmic reticulum buffering of myoplasmic calcium in bovine coronary artery smooth muscle. , 1992, The Journal of physiology.

[28]  C. Wagner-Mann,et al.  Multiple effects of ryanodine on intracellular free Ca2+ in smooth muscle cells from bovine and porcine coronary artery: modulation of sarcoplasmic reticulum function , 1992, British journal of pharmacology.

[29]  P. Schoeffter,et al.  Heterogeneity of endothelin‐sarafotoxin receptors mediating contraction of pig coronary artery , 1992, British journal of pharmacology.

[30]  C. Wagner-Mann,et al.  Endothelin mediates Ca influx and release in porcine coronary smooth muscle cells. , 1991, The American journal of physiology.

[31]  C. Wagner-Mann,et al.  Primary action of endothelin on Ca release in bovine coronary artery smooth muscle cells. , 1991, The American journal of physiology.

[32]  M. Yanagisawa,et al.  Mechanism of contraction to endothelin in isolated porcine coronary artery. , 1989, The American journal of physiology.

[33]  H. Rasmussen,et al.  Cycling of Ca2+ across the Plasma Membrane as a Mechanism for Generating a Ca2+ Signal for Cell Activation a , 1989, Annals of the New York Academy of Sciences.

[34]  N. Matsuki,et al.  Endothelin activates the dihydropyridine-sensitive, voltage-dependent Ca2+ channel in vascular smooth muscle. , 1989, Proceedings of the National Academy of Sciences of the United States of America.